Literature DB >> 5422021

Cell proliferation in human melanoma.

S Shirakawa, J K Luce, I Tannock, E Frei.   

Abstract

The cytokinetics of subcutaneous metastases in five patients with melanoma was studied. Multiple simultaneous biopsies following pulse labeling with tritiated thymidine were performed in one patient. There was relatively uniform labeling and mitotic indices among these. Within the individual tumors, there was some variation in the labeling index with small clusters of tumor cells having significantly higher labeling indices than more sparsely infiltrating tumor cells. Repetitive biopsies following pulse labeling were performed in two patients. The per cent labeled mitosis curves were similar in the two patients. By computer analysis a median G(2) period of 5.3 hr and an S period of 21 hr were obtained. The generation time (T(e)) was highly variable with a median of 3 days. This T(e) was consistent with that calculated from grain count studies in these patients. Two patients received either intermittent or continuous tritiated thymidine over a 10-20 day period. Analysis of the labeling index curve by computer fitting indicated a growth fraction of 20-30%. The growth fraction calculated by other indirect methods was consistent with the computer analysis. The potential tumor doubling time as calculated from the T(e) and growth fraction was much shorter than the actual doubling time indicating that cell loss was approximately 70% of the rate of cell production.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5422021      PMCID: PMC322585          DOI: 10.1172/JCI106333

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  27 in total

Review 1.  THE RELATIONSHIP OF THE CELL CYCLE TO TUMOR GROWTH AND CONTROL OF CELL DIVISION: A REVIEW.

Authors:  R BASERGA
Journal:  Cancer Res       Date:  1965-06       Impact factor: 12.701

2.  Uptake of tritiated thymidine by human tumors in vivo.

Authors:  R BASERGA; G C HENEGAR; W E KISIELESKI; H LISCO
Journal:  Lab Invest       Date:  1962-05       Impact factor: 5.662

3.  Cell proliferation kinetics in five human solid tumors.

Authors:  E Frindel; E Malaise; M Tubiana
Journal:  Cancer       Date:  1968-09       Impact factor: 6.860

4.  Correction for threshold error in the determination of generation times by the grain-count halving method.

Authors:  J Fried
Journal:  J Theor Biol       Date:  1969-07       Impact factor: 2.691

5.  A comparison of cell proliferation parameters in solid and ascites Ehrlich tumors.

Authors:  I F Tannock
Journal:  Cancer Res       Date:  1969-08       Impact factor: 12.701

6.  Experimental evaluation of potential anticancer agents. XIX. Sensitivity of nondividing leukemic cell populations to certain classes of drugs in vivo.

Authors:  F M Schabel; H E Skipper; M W Trader; W S Wilcox
Journal:  Cancer Chemother Rep       Date:  1965-10

7.  Kinetics of proliferation of cancer cells in neoplastic effusions in man.

Authors:  B Clarkson; K Ota; T Ohkita; A O'Connor
Journal:  Cancer       Date:  1965-10       Impact factor: 6.860

8.  In vivo studies of DNA synthesis in human normal and tumor cells.

Authors:  J Hoffman; J Post
Journal:  Cancer Res       Date:  1967-05       Impact factor: 12.701

9.  A mathematical model of the mitotic cycle and its application to the interpretation of percentage labeled mitoses data.

Authors:  J C Barrett
Journal:  J Natl Cancer Inst       Date:  1966-10       Impact factor: 13.506

10.  Reentry of nondividing leukemic cells into a proliferative phase in acute childhood leukemia.

Authors:  E F Saunders; A M Mauer
Journal:  J Clin Invest       Date:  1969-07       Impact factor: 14.808

View more
  14 in total

1.  Cell proliferation in human tumours growing in nude mice: renal cell carcinomas, larynx and hypopharynx carcinomas.

Authors:  B Maurer-Schultze; I D Bassukas; M Böswald; M Harasim
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

2.  Cell proliferation in the human mammary epithelium. Differential contribution by epithelial and myoepithelial cells.

Authors:  K Joshi; J A Smith; N Perusinghe; P Monoghan
Journal:  Am J Pathol       Date:  1986-08       Impact factor: 4.307

3.  Human melanoma FUHS-1. Description of a new cell line.

Authors:  V Misgeld; C Meisel
Journal:  Arch Dermatol Forsch       Date:  1975

Review 4.  Relationship of tumor leucocytic infiltration to host defense mechanisms and prognosis.

Authors:  J W Kreider; G L Bartlett; B L Butkiewicz
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

5.  Mechanism of growth retardation of the adenocarcinoma EO 771.

Authors:  I D Bassukas; B Maurer-Schultze
Journal:  Radiat Environ Biophys       Date:  1987       Impact factor: 1.925

6.  Analysis of proliferating hepatocytes using a monoclonal antibody against proliferating cell nuclear antigen/cyclin in embedded tissues from various liver diseases fixed in formaldehyde.

Authors:  N Kawakita; S Seki; H Sakaguchi; A Yanai; T Kuroki; Y Mizoguchi; K Kobayashi; T Monna
Journal:  Am J Pathol       Date:  1992-02       Impact factor: 4.307

7.  Autoradiographic investigations about the proliferation rate in different areas of human head and neck carcinomas.

Authors:  U Ganzer; J Lindenberger; R Nensa; A Orsulakova
Journal:  Arch Otorhinolaryngol       Date:  1980

8.  Bromodeoxyuridine in tumors and chromosomes detected with a monoclonal antibody.

Authors:  G Morstyn; S M Hsu; T Kinsella; H Gratzner; A Russo; J B Mitchell
Journal:  J Clin Invest       Date:  1983-11       Impact factor: 14.808

9.  Proliferative activity of primary cutaneous melanocytic tumours.

Authors:  T Kuwata; M Kitagawa; T Kasuga
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

10.  Measurement of cell kinetics in human tumours in vivo using bromodeoxyuridine incorporation and flow cytometry.

Authors:  G D Wilson; N J McNally; S Dische; M I Saunders; C Des Rochers; A A Lewis; M H Bennett
Journal:  Br J Cancer       Date:  1988-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.